Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
Yu-Hung ChenTso-Fu WangSung-Chao ChuChih-Bin LinLing-Yi WangKun-Han LueShu-Hsin LiuSheng-Chieh ChanPublished in: PloS one (2020)
In this preliminary study, combining PET radiomics with clinical risk factors may improve survival stratification in stage III-IV lung adenocarcinoma with actionable EFGR mutation. Our proposed scoring system may assist with optimization of individualized treatment strategies in these patients.
Keyphrases
- pet ct
- positron emission tomography
- risk factors
- end stage renal disease
- pet imaging
- computed tomography
- small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- machine learning
- peritoneal dialysis
- tyrosine kinase
- squamous cell carcinoma
- magnetic resonance imaging
- patient reported outcomes